• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Bye-Bye China?

    Decentralized Trials Fuel AI Revolution in Clinical Research

    Self-Medication: Flexibility for Patients and Drug Manufacturers

    The Single-Use Mixing Landscape: Evaluating Your Options

    DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Global Biosciences Co. Selects ValGenesis VLMS

    Eisai Appoints Chief Clinical Officer of Oncology Biz

    Nexelis Acquires GSK Vax Lab in Marburg

    Bone Therapeutics, Rigenerand Ink Cell Therapy Deal

    NovaQuest Private Equity Acquires CoreRx
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Lonza to Exit Pharma Softgels and Liquid-Filled Hard Capsules

    Cognate BioServices Announces Major Expansion

    Sanofi Unveils EUROAPI as Name of New European API Company

    Precision Medicine Group Acquires Project Farma

    Cytiva Delivers Modular Biologics Factory to Lonza
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Catalent Acquires Acorda’s INBRIJA Manufacturing Operations

    Varcode, PL Developments Form Strategic ‘Smart Tag’ Pact

    COVID-19 Vaccine Distribution: The Air Cargo Industry’s Greatest Challenge

    Thermo Fisher Expands Clinical Supply Services in Europe

    Schreiner MediPharm Joins DoseID Consortium
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Global Biosciences Co. Selects ValGenesis VLMS

    Nexelis Acquires GSK Vax Lab in Marburg

    The Future of Clinical Trials Series: Part I

    JS Bio and Etta Biotech Advancing Partnership

    Intravacc Completes Project for Provention Bio’s Vax Candidate
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management

    CDMO Cognate BioServices Teams Up with L7 Informatics
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Syngene

    PCI Pharma Services

    Adare Pharma Solutions

    Baxter BioPharma Solutions

    Cytovance Biologics
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Cytovance Biologics

    Reed-Lane

    Flow Sciences

    Alcami

    PCI Pharma Services
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    Nasal Drug Delivery

    A look at best practices for testing nasal drug delivery devices

    Nasal Drug Delivery
    Related CONTENT
    • Renaissance Lakewood
    • Shimadzu Scientific Instruments
    • AAPS Exhibitor List
    • AAPS Event Info
    • Reducing Pill Burden
    Maria Smith, senior manager & Charles Shaw, scientific advisor, Renaissance Lakewood LLC01.25.19
    Nasal spray devices are used to deliver both locally and systemically acting pharmaceutical products,1 and are readily available in the marketplace in unit dose and metered multi-dose formats. Unit dose devices are used to treat conditions such as migraine pain (Imitrex and Zomig), cancer pain (Instanyl), vitamin B12 deficiency (Nascobal), and heroin overdose (Narcan); multi-dose devices are for conditions such as allergy (Flonase, Nasacort), sinus congestion (Mucinex Sinus, Similisan Nasal Allergy Relief), cold relief  (Zicam), migraine pain (Migranal), pain management (Sprix) and nocturia (Noctiva).

    Although some interest has been shown relating to bi-dose nasal devices, they are currently less common.

    One of the benefits of nasal delivery for systemic drugs is that they can bypass the blood-brain barrier and enter the brain directly via the olfactory and trigeminal nerve pathways.2-4 Additionally, the nasal cavity has a thin, well vascularised mucosa.5 Drug molecules can transfer across this layer directly to the systemic blood circulation6,7 thereby avoiding first-pass hepatic and/or intestinal metabolism.

    Spray Characterization Tests
    For all spray characterization tests, the spray device is actuated using controlled parameters—force, speed, acceleration, stroke length.

    Spray Pattern. The shape of the plume from a bird’s eye view when looking directly towards the actuator orifice as the product is emitted from the device. Testing is performed at fixed distances from the actuator tip, and the spray pattern is characterized using the following parameters:
    • Dmax—the length of the longest line that passes through the weighted center of mass drawn within the perimeter of the spray;
    • Dmin—the length of the shortest line that passes through the weighted center of mass drawn within the perimeter of the spray;
    • Ovality ratio—the ratio of Dmax/Dmin;
    • Ellipticity—the ratio of the major and minor axes of the ellipse; and
    • Area—the cross-sectional area defined by the spray.
    • Plume Geometry—the shape of the plume when looking at the spray from the side as the product is emitted from the device. The plume geometry is characterized using the following parameters:
    • Plume Angle—the angle created at the base of the plume as the product is emitted from the actuator orifice; and
    • Plume Width—the width of the plume at a specified distance from the actuator tip.
    The pump design, size and shape of the actuator orifice, size of metering chamber (for multi-dose devices), and formulation characteristics (e.g., viscosity10) can affect the spray pattern and plume geometry.

    Single Actuation Content/Delivered Dose Uniformity.11 A measure of the amount of active ingredient contained within individual sprays across the lifetime of a single device for multi-dose sprays, and between devices produced throughout the course of a packaging run—e.g., from the beginning, middle, and end of the filling process. The emitted spray is captured, and the content of active ingredient, or other functional ingredient, is assayed using the normal product assay method (e.g., HPLC).

    This testing is performed to ensure that the dosage per actuation complies with the stated label claim, does not change from one actuation to the next, and does not vary from one device to the next.

    Droplet Size Distribution.11 The droplet size within the spray plume in terms of cumulative volume distributions:
    • Dv10, Dv50, Dv90—the volume median diameter (or Dv50) value indicates that half of the spray volume is contained in droplets that are smaller than this value, and half is contained in droplets that are larger than this value. Similarly, the Dv10 and Dv90 values indicate that 10% and 90%, respectively, of the spray volume is contained in droplets that are smaller than these values;
    • Span—the span quantifies the spread of the droplet size distribution and is calculated by the following equation: (Dv90 − Dv10)/Dv50; and
    • %<10 μm—the percentage of droplets that are less than 10 μm in diameter.
    Droplet size is related to the ease of atomization of the formulation. A decrease in viscosity or surface tension should help the formulation to atomize and give rise to smaller droplets10 and, consequently, a larger spray pattern surface area.

    For nasal sprays, droplets that are excessively large (Dv90 > 300 μm) will have a tendency to either drip out of the nose,12 or hit the back of the throat and be swallowed. The value for %<10 μm provides a risk estimate of small droplets that may be deposited into the lung. Neither of these situations is the intended route of administration and will, therefore, have an impact on the effectiveness of the delivered dose.

    Dose Weight. Dose weight, or pump delivery, testing is performed to assess pump-to-pump reproducibility both within a given product batch, and between different batches of product. The amount of product dispensed by the device will have a direct impact on the efficacy, and safety, in the case of over delivery, of the product. The acceptance criteria in USP<698> (Delivered Volume) may be used as a basis for this testing.

    Priming and Repriming (Effect of Resting Time). Typically, multi-dose metered nasal spray devices have a dip tube going from the actuator into the product. This is to enable liquid product to be delivered when the device is used in an upright orientation. The device will need to be primed by actuating several times to fill the dip tube before the full dose is emitted. The number of actuations needed to prime the device is obtained by measuring the emitted dose weight until the full (label claim) dose is achieved.

    During normal use, these devices will slowly “lose” their prime. That is, the product in the dip tube will slowly run back out into the product container. The time period after which the device needs additional priming actuations to deliver the full dose, and the number of actuations needed to reprime, should be determined.

    Effect of Dosing Orientation. To cover the case where a user might not actuate the nasal spray in an upright orientation, nasal characterization testing should be performed at several different angles from upright/vertical. This is particularly important for multi-dose devices where air might get sucked into the dip tube, thereby reducing the delivered dose.

    Number of Doses and Tail-Off Characteristics. The number of doses contained in a multi-dose device will depend on the actuation volume, the priming needs, and the container fill weight. This testing is performed by recording the weight of each actuation until the container is exhausted.

    After the stated number of  “useful” doses has been expelled some product will remain in the container.  The profile of the sprays—spray content uniformity, droplet size distribution—should be determined immediately before and then after the labeled number of doses have been expelled until the container is exhausted.

    Other Tests
    Particle Size Distribution (Suspensions). For suspension nasal sprays, the size distribution of the drug substance particles in the formulation should be determined. Furthermore, if the formulation contains a suspending agent (e.g., Avicel from FMC BioPolymer) the method used must be able to distinguish between the drug particle and the suspending agent. Smaller drug substance particles have a relatively larger surface area. A larger surface area will affect the rate of dissolution and absorption of the drug, thereby influencing the pharmacokinetics.

    Particulate Matter. The presence of particulate matter, which can originate during manufacturing from formulation components, container and closure components, and the manufacturing environment, needs to be assessed. Typically, the cumulative number of particles ≥ 10 µm and ≥ 25 µm, and in some instances ≥ 50 µm, are determined. USP<788> (Particulate Matter in Injections) and USP<789> (Particulate Matter in Ophthalmic Solutions) outline applicable testing procedures.

    Device Robustness. The performance characteristics of the device should be studied after different handling situations. Baseline testing should be performed prior to commencing the studies. Product in its shipping or shelf container should be shipped, pre-conditioned at different temperatures/humidities, dropped,13 and vibrated14 before being re-tested to determine any change in performance resulting from possible in-market events.

    General Tests. In addition to the above, the following list of general formulation tests may also be required: description; identification; assay; impurities and degradation products; preservatives and stabilizing excipients assay; microbial limits; net content; weight loss (stability); leachables (stability); pH; osmolality; viscosity; temperature cycling; and photostability.

    Examples of Equipment
    Spray Pattern/Plume Geometry. Measured using a non-impaction laser sheet-based instrument. A high speed camera is used to capture the interference pattern of the spray with the laser sheet. Instrument suppliers include Proveris Scientific Corp. (Marlboro, MA), InnovaSystems Inc. (Moorestown, NJ) and Oxford Lasers Inc. (Shirley, MA).

    Droplet Size Distribution. Measured using a laser diffraction system. As the nasal spray droplets pass through the laser beam, the smaller droplets diffract the laser light at larger angles than the larger droplets. The diffracted light is captured on a series of concentric photodetectors, and then converted into a measurement of the droplet size. Instrument suppliers include Malvern Panalytical Inc. (Westborough, MA) and Sympatec Inc. (Pennington, NJ).

    Particle Size Distribution and Particulate Matter. USP<788> (Particulate Matter in Injections) lists methods for determining particle count by light obscuration (Method 1) and by microscopy (Method 2).
    The light obscuration method uses a particle sizer to determine the size and number of particles in a solution by measuring the amount of light a particle blocks or scatters when it passes through the detection window area of the instrument. Examples of instruments include the HIAC range (Beckman Coulter Life Sciences, Indianapolis, IN), the Mastersizer range (Malvern Panalytical Inc., Westborough, MA), and particle sizers from Shimadzu Scientific Instruments (Somerset, NJ) and Horiba Scientific (Ederson, NJ).

    Microscopic evaluation can provide information on the size of particles, the extent of agglomerates, and particle morphology. Microscopy can also be used to determine different types of particles in a sample, for example, drug particles and suspending agents. The drawback with microscopy is that it is a manual technique and, therefore, time consuming.

    Morphological imaging instruments are available which enable the automated measurement of particle size, shape and chemical identity. These instruments use a combination of image analysis and morphologically-directed Raman spectroscopy. Examples of this type of instrument are the Morphologi range of instruments from Malvern Panalytical Inc. (Westborough, MA).

    Renaissance Lakewood, LLC has experience in developing, qualifying and validating methods to characterize the spray characteristics of nasal sprays in addition to transferring and validating methods which have been developed at third party facilities. Visit www.renpharm.com to learn more. 

    References
    1. J.D. Ehrick, S.A. Shah, C. Shaw, V.S. Kulkarni, I. Coowanitwong, S. De and J.D. Suman. Chapter 5, “Considerations for the Development of Nasal Dosage Forms” in “Sterile Product Development: Formulation, Process, Quality and Regulatory Considerations”. AAPS Advances in the Pharmaceutical Sciences Series, Volume 6, 2013, pp 99-144. Springer NY
    2. Intranasal Drug Delivery Bypasses the Blood–Brain Barrier. Neurology Reviews, 2016 April; 24(4):1, 40-41
    3. W. Ying. The nose may help the brain: intranasal drug delivery for treating neurological diseases. Future Neurol 2008; 3(1): 1-4
    4. S.V. Dhuria, L.R. Hanson and W.H. Frey. Intranasal delivery to the central nervous system: Mechanisms and experimental considerations. J Pharm Sci 2010; 99(4): 1654-1673
    5. D.F. Proctor and I. Andersen. The nose. Upper airway physiology and the atmospheric environment, Elsevier Biomedical Press, Amsterdam, 1982
    6. B.L. Laube. Devices for aerosol delivery to treat sinusitis. J Aerosol Med 2007; 20: S5-S17
    7. S.P. Newman, G.R. Pitcairn and R.N. Dalby. Drug delivery to the nasal cavity: In vitro and in vivo assessment. Crit Rev Ther Drug Carrier Syst 2004; 21: 21-66
    8. FDA Guidance for Industry: Nasal Spray and Inhalation Solution, Suspension, and Spray Drug Products – Chemistry, Manufacturing, and Controls Documentation. July 2002
    9. V.S. Kulkarni and C. Shaw. Essential Chemistry for Formulators of Semisolid and Liquid Dosages. Elsevier (Academic Press) USA, 2015: 211-216
    10. V.S. Kulkarni, C. Shaw, M. Smith and J. Brunotte. Characterization of plumes of nasal spray formulations containing mucoadhesive agents sprayed from different types of device. Poster presentation, AAPS annual meeting, San Antonio, Texas. November 2013
    11. USP<601> Inhalation and nasal drug products: Aerosols, sprays, and powders – performance quality tests
    12. V. Kulkarni and C. Shaw. Formulation and characterization of nasal sprays. Inhalation June 2012: 10-5
    13. ASTM D5276-98. Standard Test Method for Drop Test of Loaded Containers by Free Fall
    14. ASTM D 999-08. Standard Test Methods for Vibration Testing of Shipping Containers
    Related Searches
    • Sterile
    • leachables
    • Filling
    • fda
    Suggested For You
    Renaissance Lakewood Renaissance Lakewood
    Shimadzu Scientific Instruments Shimadzu Scientific Instruments
    AAPS Exhibitor List AAPS Exhibitor List
    AAPS Event Info AAPS Event Info
    Reducing Pill Burden Reducing Pill Burden
    RSSL Expands Subvisible Particle Analysis Service RSSL Expands Subvisible Particle Analysis Service
    Recro Gainesville Discusses Capabilities & New Site Recro Gainesville Discusses Capabilities & New Site
    Lonza Talks Drug Product Services Expansion Lonza Talks Drug Product Services Expansion
     Sandoz Recalls Lot of Losartan Sandoz Recalls Lot of Losartan
    CMIC Details Services & Growth CMIC Details Services & Growth
    PPD Discusses Lab Trends PPD Discusses Lab Trends
    Thermo Scientific Launches Orbitrap ID-X with Mass Spec Software Thermo Scientific Launches Orbitrap ID-X with Mass Spec Software
    AAPS Names Manuscript Award Winners AAPS Names Manuscript Award Winners
    Evonik Launches Combo Polymer for Enteric Coatings Evonik Launches Combo Polymer for Enteric Coatings
    BIA Separations Opens New Upstream Processing Facility BIA Separations Opens New Upstream Processing Facility

    Related Features

    • Drug Delivery | Injectables
      Self-Medication: Flexibility for Patients and Drug Manufacturers

      Self-Medication: Flexibility for Patients and Drug Manufacturers

      Bringing together self-medication with auto-injectors and sustainable secondary packaging.
      Matthias Heinrichs, Head of Product Management and Project Engineering, Syntegon Technology 11.17.20

    • Drug Delivery
      Wet Wipes Increased Prevalence in Drug Development

      Wet Wipes Increased Prevalence in Drug Development

      A number of factors including patient preference are driving the growth of wet wipes in pharma.
      John Waddell, Business Development Director – Pharma, PDI Contract Manufacturing 10.14.20

    • Drug Delivery
      Not Your Father’s Oral Thin Film

      Not Your Father’s Oral Thin Film

      A look at how oral film drug delivery is evolving.
      Rodolphe Obeid, Vice President of Operations, IntelGenx 06.04.20


    • Drug Delivery | Regulatory Affairs
      Regulatory Overhaul for Medical Devices

      Regulatory Overhaul for Medical Devices

      Implications for the pharmaceutical industry.
      Elizma Parry, Director, Global Clinical Practice, Maetrics 06.04.20

    • Drug Delivery
      CEO Spotlight: Will Downie

      CEO Spotlight: Will Downie

      Vectura’s chief executive talks trends in the inhaled-drug market, and the company’s transition into a CDMO
      Tim Wright, Editor, Contract Pharma 04.01.20

    • Biologics, Proteins, Vaccines | Drug Delivery | Drug Development
      Knowledge Sharing: Biologics Development and Delivery

      Knowledge Sharing: Biologics Development and Delivery

      The increasing importance of sharing information to build awareness and better manage the complexities of drug development.
      Fran L. DeGrazio, Vice President of Scientific Affairs and Technical Services, West Pharmaceutical Services 09.16.19


    • Drug Delivery | Drug Development
      Traveling Toward the Intersection of Drug Development and Delivery

      Traveling Toward the Intersection of Drug Development and Delivery

      Overcoming the challenges of delivering drugs to patients.
      Louise Righton, Global Marketing Operations Manager, 3M Drug Delivery Systems 06.12.18

    • Drug Delivery | Solid Dosage/Creams/Ointments
      FDCs on the Rise

      FDCs on the Rise

      Fixed-dose combination drugs continue to gain traction due to a multitude of benefits they offer, including speed to market a
      Betsy Louda, Associate Editor, Contract Pharma 03.09.18

    • Drug Delivery
      The Future of Inhaled Medications and Inhalation Technology

      The Future of Inhaled Medications and Inhalation Technology

      Formulations, devices and strategy through non-clinical development
      Simon Moore, Envigo 10.11.17


    • Drug Delivery
      Digital Drug Delivery: A Snapshot in Time

      Digital Drug Delivery: A Snapshot in Time

      Technology is transforming the future of drug delivery
      Sam Van Alstyne, 3M Drug Delivery Systems 10.11.17

    • Drug Delivery | Drug Development
      Two Strikes, Two Outs, or Time Out? Inhalation for Systemic Effect

      Two Strikes, Two Outs, or Time Out? Inhalation for Systemic Effect

      The challenges of using the lung as a portal for the treatment of systemic conditions
      Tugrul Kararli, Kurt Sedo, Josef Bossart, PHARMACIRCLE 10.11.16

    • Aseptic Processing | Biosimilars | Drug Delivery | Logistics | Supply Chain
      Improving Packaging Processes to Meet Regulatory and Patient Needs

      Improving Packaging Processes to Meet Regulatory and Patient Needs

      The rise of advanced automation and packaging technologies
      06.02.16


    • Biosimilars | Drug Delivery | Injectables | Parenterals | Serialization | Supply Chain | Vials
      Contract Packaging Market Trends

      Contract Packaging Market Trends

      Contract packagers talk about hot growth areas and the looming 2017 DSCSA deadline
      Tim Wright, Editor 06.02.16

    • Drug Delivery | Drug Development | Excipients | Process Development | Process Validation | Risk Management | Validation
      Process Development Trends

      Process Development Trends

      An approach to process development of pMDIs using cold fill and pressure fill technology
      Steve Haswell, 3M Drug Delivery Systems 05.05.16

    • Aseptic Processing | Biosimilars | cGMP Manufacture | Drug Delivery | Injectables | Parenterals
      Injectables: The New Oral?

      Injectables: The New Oral?

      The growth trend of injectables continues across the pharma landscape.
      Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC 04.05.16

    Trending
    • Lonza To Exit Pharma Softgels And Liquid-Filled Hard Capsules
    • Roche Canada To Invest $500M To Create 500 Jobs In Ontario
    • Grifols Begins COVID-19 Plasma Treatment Trial
    • Fujifilm To Invest $2B In US Manufacturing Site
    • Virtual Clinical Trials: The Future Of Dermatology Studies
    Breaking News
    • Global Biosciences Co. Selects ValGenesis VLMS
    • Eisai Appoints Chief Clinical Officer of Oncology Biz
    • Nexelis Acquires GSK Vax Lab in Marburg
    • Bone Therapeutics, Rigenerand Ink Cell Therapy Deal
    • NovaQuest Private Equity Acquires CoreRx
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Modeling Process Safety Workflows in Pharmaceutical Manufacturing Scale-Up
    • Ensuring Quality During the Transfer and Scale Up of Rx Drugs
    • Inspecting the Unexpected
    • Cold Chain Trends
    • Catering for the Complex
    • Biopharma Contract Manufacturing: Robust Growth Ahead
    • DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    • The Single-Use Mixing Landscape: Evaluating Your Options
    • Self-Medication: Flexibility for Patients and Drug Manufacturers
    • Decentralized Trials Fuel AI Revolution in Clinical Research
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Euromonitor Names Top Ten Trends for 2021
    Study Highlights Differences Between EPA's and DHA's Effect on Sleep
    BGG Obtains U.S. Patent on AstaZine Natural Astaxanthin for Heart Function During Exercise
    Coatings World

    Latest Breaking News From Coatings World

    IGL Coatings Launches Graphene Reinforced Dual System Ceramic Coating
    Miller Paint Declares Simple Serenity its 2021 Color of the Year
    TAUBMANS Paint by PPG Releases ‘Chromatic Joy’ Palettes
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Researchers Successfully ‘Fine Tune’ New Thermoplastic Biomaterial
    RSIP Vision Announces Versatile Medical Image Segmentation Tool
    Vance Street Capital Adds Operating Partner
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Global Biosciences Co. Selects ValGenesis VLMS
    Eisai Appoints Chief Clinical Officer of Oncology Biz
    Nexelis Acquires GSK Vax Lab in Marburg
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Top Beauty Brands in the World—And Most Loved Fragrances
    P&G Reports Q2 Results
    A Lacquering Technique Makes Very Good Girl by Carolina Herrera Shine
    Happi

    Latest Breaking News From Happi

    Ross Introduces Double Cone Tumble Blender
    Colonial Chemical Announces New Facility
    Ashland Acquires Schülke & Mayr's Personal Care Business
    Ink World

    Latest Breaking News From Ink World

    Morancé Soudure France Adds Comexi F2 MC 10-color Flexo Press
    THIMM Group Installs 1st Koenig & Bauer CorruFLEX
    Cowan Graphics Adds Fujifilm Inca OnsetX3 HS
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Domino grows installation and service teams
    ABG keeps pace with demand with recruitment drive
    Acucote expands FSC-certified portfolio
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    First Quality Launches Incognito by Prevail
    Essity Launches Reusable Underwear Product
    Honeywell Delivered 225 Million Masks in December
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    DJO Acquires Trilliant Surgical
    FDA Breakthrough Device Designation Granted to Spiderwort's Spinal Cord Technology
    Bioventus Appoints SVP of Operations
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    UDC Subsidiary Adesis' Website Wins 2020 MarCom Platinum Award
    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Graphene Flagship Launches Redesigned Website

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login